The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zoledronic acid Sandoz 4mg/5ml Concentrate for Solution for Infusion

4 mg/5 millilitre(s) Concentrate for solution for infusion

Rowex LtdPA0711/203/001

Main Information

Trade NameZoledronic acid Sandoz 4mg/5ml Concentrate for Solution for Infusion
Active SubstancesZoledronic acid
Strength4 mg/5 millilitre(s)
Dosage FormConcentrate for solution for infusion
Licence HolderRowex Ltd
Licence NumberPA0711/203/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA08 zoledronic acid


Licence Issued03/08/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back